| The economics of priority review vouchers. | |
| | |
MedLine Citation:
|
PMID: 20732445 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Priority review vouchers (PRVs) were introduced in 2007 by the US Congress as an incentive mechanism to spur pharmaceutical firms' R&D efforts for neglected diseases (NDs). A voucher, which a firm can obtain upon approval of a new treatment for NDs, entitles the holder to prioritize the FDA review for any drug. The proposal generated much controversy regarding its ability to effectively stimulate R&D for NDs. Here, after reviewing the main issues of the debate, i use a stylized economic model to discuss the strength of PRVs as an economic incentive to invest in research. My findings suggest that R&D investments might be higher when the developer could prioritize a valuable compound. |
| | |
Authors:
|
Nicola Dimitri |
Related Documents
:
|
123015 - Chymopapain chemonucleolysis in lumbar disk disease. 11347725 - Temporal patterns of nsaid spontaneous adverse event reports: the weber effect revisited. 19901485 - Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin. 12189465 - Vasculitis induced by zafirlukast therapy. 15040625 - Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements. 3560075 - Lithopedion. a case report. |
Publication Detail:
|
Type: Journal Article Date: 2010-08-21 |
Journal Detail:
|
Title: Drug discovery today Volume: 15 ISSN: 1878-5832 ISO Abbreviation: Drug Discov. Today Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9604391 Medline TA: Drug Discov Today Country: England |
Other Details:
|
Languages: eng Pagination: 887-91 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Faculty of Economics, University of Siena, 53100, Italy. dimitri@unisi.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO ce...
Next Document: The MPTP marmoset model of parkinsonism: a multi-purpose non-human primate model for neurodegenerati...